Back to Search
BRENNAN CEBULA, M.D.
M.D.
Infectious Disease Physician
NPI: 1619367943Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
29444(NE)
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
29444(NE)
Research & Publications (18)
Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine.
PMID 19584709·Anticancer Drugs·2009
8-other
Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
PMID 19276301·Lupus·2009
8-other
CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
PMID 19240243·Cancer Epidemiol Biomarkers Prev·2009
8-other
The effect of repeated exposures to low-dose UV radiation on the apoptosis of peripheral blood mononuclear cells.
PMID 19221257·Arch Dermatol·2009
2-rct
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
PMID 18076637·Eur J Haematol·2008
8-other
Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis.
PMID 17965117·Ann Rheum Dis·2008
8-other
Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
PMID 17849117·Ann Hematol·2008
8-other
Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
PMID 17635235·Eur J Haematol·2007
3-trial
Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
PMID 17169808·Leuk Lymphoma·2006
8-other
No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells.
PMID 17038891·Ther Drug Monit·2006
8-other
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
PMID 16948126·Cancer·2006
3-trial
Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells.
PMID 16630656·Leuk Res·2006
8-other
Circulating endothelial cells in patients with acute myeloid leukemia.
PMID 16313261·Eur J Haematol·2005
8-other
Circulating endothelial microparticles in patients with acute myocardial infarction.
PMID 16123851·Kardiol Pol·2005
8-other
In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
PMID 15813915·Eur J Haematol·2005
8-other
Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.
PMID 15621786·Leuk Lymphoma·2005
8-other
Exposure to low doses of solar-simulated radiation induces an increase in the myeloid subtype of blood dendritic cells.
PMID 15379868·Scand J Immunol·2004
8-other
Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia.
PMID 15254670·Neoplasma·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 8960 BROWN DR, BLDG 39 4TH FLOOR
BETHESDA, MD 20889 - Phone
- (301) 295-6400
Quick Facts
- NPI
- 1619367943
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 3
- Publications
- 18
Are you this provider?
Claim Your Profile